The 45-year-old comedian posted a wetsuit photo thanking the drug. She has lost 50 pounds on it since going public in March 2025.
Recap by typeshit. Full story at The Daily Beast.
2:06:18
A live Q&A from FitFlavorFun taking viewer questions on Zepbound, Ozempic, Wegovy, retatrutide and Korglutide.
People familiar with the matter say the plan under review includes more safeguards for patients than first expected. A policy step worth watching.
Celebrity paparazzi item on Amanda Bynes stepping out in a miniskirt, framed around her reported Ozempic use. Little detail beyond the photos.
The show is collecting experiences from people microdosing GLP-1 drugs, including why they tried it and how they got the medication.
At ASN Kidney Week 2026, the phase 2b data showed lower kidney pressure and kidney fat at 24 weeks, but measured GFR did not change.
An investor explainer on how the peptide market reaches past GLP-1 weight loss drugs.
Loading…